Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:16 PM
Ignite Modification Date:
2025-12-24 @ 7:16 PM
NCT ID:
NCT00464503
Eligibility Criteria:
Inclusion Criteria:
* Male, age range: 25 - 65 years
* Non-smoker
* Proteinuria: \< 60 mg/24 hours
* Dipstick negative hematuria
* Bloodpressure: \< 135 mm systolic, \< 85 mm dyastolic
* Waist circumference: \< 94 cm
Exclusion Criteria:
* Treatment with lipid-lowering drugs \<1 year prior to the study
* Known history of diabetes or fasting glucose level: \< 110 mg/dl
* Anti-hypertensive medication
* Life-expectancy \< 1 year
* Pharmacological treatment with inotropes
* Acute or chronic inflammatory process, use if anti-inflammatory drugs or immunosuppression
* Clinically active malignant disease
* Administration of any investigational drug within 30 days preceding study start and during the study
* Known intolerance to rosuvastatin or other statins
* Acute or chronic liver disease or ALAT\>2.0 x upper limit of normal (ULN) at enrolment visit.
* Chronic muscle disease such as dermatomyositis or polymyositis or unexplained creatinine kinase (CK) above 3 x ULN at enrolment.
* Uncontrolled hypothyroidism as indicated by a thyroid stimulating hormone (TSH) \> 2 x ULN at enrolment.
* Renal insufficiency: creatinine \> 2.0mg/dl
* Known or suspect alcohol or drug abuse.
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
25 Years
Maximum Age:
65 Years
Study:
NCT00464503
Study Brief:
Protocol Section:
NCT00464503